NEW YORK – ArcherDx today announced a non-exclusive partnership with Illumina to develop next-generation sequencing-based in vitro diagnostic tests.
NEW YORK – ArcherDx today announced a non-exclusive partnership with Illumina to develop next-generation sequencing-based in vitro diagnostic tests.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.